These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27174426)

  • 21. Video microscope recording of the dynamic course of thrombosis and thrombolysis of the retinal vein in rabbits.
    Wu J; Zhou X; Hu Y; Zhang T; Ma Z; Li X; Su L; Wang J; Lin S
    Retina; 2010 Jun; 30(6):966-70. PubMed ID: 20094009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
    Gadbut AP; Schullek JR; Hanel AM; MacAllan DR
    Anal Biochem; 1999 May; 270(1):24-32. PubMed ID: 10328761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of tPA significantly affects antithrombotic therapy by a GPIIb/IIIa antagonist, but not by a thrombin inhibitor in mice.
    Matsuno H; Kozawa O; Ueshima S; Matsuo O; Collen D; Uematsu T
    Thromb Haemost; 2000 Apr; 83(4):605-9. PubMed ID: 10780325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolytic Enzymes of Microbial Origin: A Review.
    Diwan D; Usmani Z; Sharma M; Nelson JW; Thakur VK; Christie G; Molina G; Gupta VK
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats?
    Bird E; Tamura J; Bostwick JS; Steinbacher TE; Stewart A; Liu Y; Baumann J; Feyen J; Tamasi J; Schumacher WA
    Thromb Res; 2007; 120(4):549-58. PubMed ID: 17229457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial thrombosis model with photochemical reaction in guinea-pig and its property.
    Takiguchi Y; Hirata Y; Wada K; Nakashima M
    Thromb Res; 1992 Aug; 67(4):435-45. PubMed ID: 1412222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.
    Özkan M; Çakal B; Karakoyun S; Gürsoy OM; Çevik C; Kalçık M; Oğuz AE; Gündüz S; Astarcioglu MA; Aykan AÇ; Bayram Z; Biteker M; Kaynak E; Kahveci G; Duran NE; Yıldız M
    Circulation; 2013 Jul; 128(5):532-40. PubMed ID: 23812180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental thrombosis model induced by free radicals. Application to aspirin and other different substances.
    Jourdan A; Aguejouf O; Imbault P; Doutremepuich F; Inamo J; Doutremepuich C
    Thromb Res; 1995 Jul; 79(1):109-23. PubMed ID: 7495098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serine-proteases as plasminogen activators in terms of fibrinolysis.
    Flemmig M; Melzig MF
    J Pharm Pharmacol; 2012 Aug; 64(8):1025-39. PubMed ID: 22775207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current perspectives in the treatment of thrombotic disorders.
    Drouet L; Caen JP
    Semin Thromb Hemost; 1989 Apr; 15(2):111-22. PubMed ID: 2665082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New strategies and perspectives in thrombolytic therapy].
    Bode C; Kübler W
    Internist (Berl); 1992 Apr; 33(4):258-64. PubMed ID: 1612850
    [No Abstract]   [Full Text] [Related]  

  • 35. Vessel wall injury and arterial thrombosis induced by a photochemical reaction.
    Saniabadi AR; Umemura K; Matsumoto N; Sakuma S; Nakashima M
    Thromb Haemost; 1995 May; 73(5):868-72. PubMed ID: 7482418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound.
    Kawata H; Uesugi Y; Soeda T; Takemoto Y; Sung JH; Umaki K; Kato K; Ogiwara K; Nogami K; Ishigami K; Horii M; Uemura S; Shima M; Tabata Y; Saito Y
    J Am Coll Cardiol; 2012 Dec; 60(24):2550-7. PubMed ID: 23158532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial.
    Özkan M; Gündüz S; Biteker M; Astarcioglu MA; Çevik C; Kaynak E; Yıldız M; Oğuz E; Aykan AÇ; Ertürk E; Karavelioğlu Y; Gökdeniz T; Kaya H; Gürsoy OM; Çakal B; Karakoyun S; Duran N; Özdemir N
    JACC Cardiovasc Imaging; 2013 Feb; 6(2):206-16. PubMed ID: 23489534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
    Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
    Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.